A longitudinal study of post-traumatic stress, depressive, and anxiety symptoms trajectories in subjects with bipolar disorder during the COVID-19 pandemic.
Anxiety
COVID-19
PTSD
bipolar disorder
depression
Journal
European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820
Informations de publication
Date de publication:
13 01 2022
13 01 2022
Historique:
pubmed:
14
1
2022
medline:
9
2
2022
entrez:
13
1
2022
Statut:
epublish
Résumé
Bipolar disorder (BD) is recognized to be at high risk for developing negative psychopathological sequelae to potentially traumatic events. Nevertheless, scant data are still available about the effects of the COVID-19 emergency on the clinical course of BD. The present study examined prospectively the development and trajectories of post-traumatic stress, depressive, and anxiety symptoms among subjects with BD that were followed in an outpatient psychiatric clinic at the time of pandemic onset. A cohort of 89 subjects with BD was enrolled during the first wave of the COVID-19 pandemic, and assessed at baseline (T0), 2-months (T1), and 6-months (T2) follow-up. A K-means cluster analysis was used to identify distinct trajectories of depressive, anxiety, and post-traumatic stress symptoms during the three time points. We identified three trajectories: the Acute reaction (13.5%); the Increasing severity (23.6%); and the Low symptoms (62.9%) groups, respectively. In the Acute reaction group a significant prevalence of female gender was reported with respect to the Low symptoms one. Subjects in the Increasing severity group reported significantly lower employment rate, and higher rate of relatives at risk for COVID-19 medical complications. Subjects in the Increasing Severity group reported higher rates of previous hospitalization and manic symptoms at baseline than those included in the Low symptoms one. Our results describe three distinct symptom trajectories during the COVID-19 emergency in a cohort of subjects suffering from BD, suggesting the need of a long-term follow-up for detecting the impact of the COVID-19 pandemic in this vulnerable population.
Sections du résumé
BACKGROUND
Bipolar disorder (BD) is recognized to be at high risk for developing negative psychopathological sequelae to potentially traumatic events. Nevertheless, scant data are still available about the effects of the COVID-19 emergency on the clinical course of BD. The present study examined prospectively the development and trajectories of post-traumatic stress, depressive, and anxiety symptoms among subjects with BD that were followed in an outpatient psychiatric clinic at the time of pandemic onset.
METHODS
A cohort of 89 subjects with BD was enrolled during the first wave of the COVID-19 pandemic, and assessed at baseline (T0), 2-months (T1), and 6-months (T2) follow-up. A K-means cluster analysis was used to identify distinct trajectories of depressive, anxiety, and post-traumatic stress symptoms during the three time points.
RESULTS
We identified three trajectories: the Acute reaction (13.5%); the Increasing severity (23.6%); and the Low symptoms (62.9%) groups, respectively. In the Acute reaction group a significant prevalence of female gender was reported with respect to the Low symptoms one. Subjects in the Increasing severity group reported significantly lower employment rate, and higher rate of relatives at risk for COVID-19 medical complications. Subjects in the Increasing Severity group reported higher rates of previous hospitalization and manic symptoms at baseline than those included in the Low symptoms one.
CONCLUSIONS
Our results describe three distinct symptom trajectories during the COVID-19 emergency in a cohort of subjects suffering from BD, suggesting the need of a long-term follow-up for detecting the impact of the COVID-19 pandemic in this vulnerable population.
Identifiants
pubmed: 35022099
doi: 10.1192/j.eurpsy.2021.2247
pii: S0924933821022471
pmc: PMC8853854
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e8Références
J Psychiatr Res. 2020 Nov;130:177-179
pubmed: 32823051
J Affect Disord. 2013 Sep 5;150(2):450-5
pubmed: 23706842
Am J Psychiatry. 1998 May;155(5):630-7
pubmed: 9585714
World Psychiatry. 2020 Jun;19(2):129-130
pubmed: 32394569
J Affect Disord. 2020 Dec 1;277:337-340
pubmed: 32858315
J Clin Psychiatry. 2017 May;78(5):e506-e514
pubmed: 28570791
Eur Psychiatry. 2020 Dec 21;64(1):e10
pubmed: 33342444
Psychoneuroendocrinology. 2020 Dec;122:104869
pubmed: 32956989
World Psychiatry. 2020 Jun;19(2):130-131
pubmed: 32394549
CNS Spectr. 2009 May;14(5):262-6
pubmed: 19407725
Am J Epidemiol. 2017 Dec 15;186(12):1310-1318
pubmed: 29036483
World Psychiatry. 2021 Feb;20(1):54-55
pubmed: 33131217
J Glob Health. 2020 Dec;10(2):020505
pubmed: 33110588
Br J Psychiatry. 2015 May;206(5):417-23
pubmed: 25657356
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychiatry Clin Neurosci. 2017 Jan;71(1):6-17
pubmed: 27500795
J Clin Psychiatry. 2014 Apr;75(4):e323-31
pubmed: 24500332
Rev Psiquiatr Salud Ment (Engl Ed). 2020 Apr - Jun;13(2):105-110
pubmed: 32376131
Eur Psychiatry. 2020 Aug 26;63(1):e81
pubmed: 32843115
Medicina (Kaunas). 2021 Mar 24;57(4):
pubmed: 33804912
Psychiatry Res. 2017 May;251:142-147
pubmed: 28199913
Ann Gen Psychiatry. 2018 May 4;17:17
pubmed: 29755579
Psychol Med. 2021 May;51(7):1129-1139
pubmed: 32008580
Front Psychiatry. 2020 May 26;11:489
pubmed: 32574243
Psychiatry Res. 2010 May 15;177(1-2):139-43
pubmed: 20363031
SAGE Open Med. 2020 Dec 14;8:2050312120981178
pubmed: 33403113
Psychiatry Res. 2020 Aug;290:113172
pubmed: 32512357
Front Psychiatry. 2021 Feb 24;12:634765
pubmed: 33716829
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
J Affect Disord. 2017 Jan 15;208:298-308
pubmed: 27794254
Br J Psychiatry. 1978 Nov;133:429-35
pubmed: 728692
Eur Psychiatry. 2020 Apr 01;63(1):e32
pubmed: 32234102
Front Psychiatry. 2020 Dec 03;11:580736
pubmed: 33343419
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Depress Anxiety. 2019 Jun;36(6):490-498
pubmed: 30681235
Gen Hosp Psychiatry. 2020 Sep - Oct;66:89-95
pubmed: 32750604
Int J Environ Res Public Health. 2020 Aug 26;17(17):
pubmed: 32858810
J Psychiatr Res. 2017 Jun;89:55-64
pubmed: 28182961
World Psychiatry. 2021 Feb;20(1):124-130
pubmed: 33026219
J Sex Med. 2009 Nov;6(11):3063-70
pubmed: 19732307
Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S140-4
pubmed: 27157399
PLoS One. 2013 Apr 11;8(4):e59236
pubmed: 23593134
J Affect Disord. 2020 Oct 1;275:69-77
pubmed: 32658826
J Trauma Stress. 2010 Jun;23(3):331-9
pubmed: 20564365
Eur Psychiatry. 2020 May 29;63(1):e50
pubmed: 32468988
Psychiatry Res. 2012 Aug 15;198(3):436-40
pubmed: 22436352
Bipolar Disord. 2004 Dec;6(6):470-9
pubmed: 15541062
J Affect Disord. 2010 Jun;123(1-3):249-57
pubmed: 19765828
Eur Psychiatry. 2020 May 20;63(1):e45
pubmed: 32431255
World Psychiatry. 2020 Oct;19(3):406-407
pubmed: 32931089
J Affect Disord. 2021 Mar 1;282:1226-1233
pubmed: 33601700
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Bipolar Disord. 2008 Mar;10(2):293-302
pubmed: 18271909
J Clin Psychiatry. 2006 Mar;67(3):394-9
pubmed: 16649825
Brain Behav Immun. 2020 Jul;87:100-106
pubmed: 32353518
Sci Adv. 2020 Oct 14;6(42):
pubmed: 32948511
Eur Psychiatry. 2020 Sep 28;63(1):e87
pubmed: 32981568
Eur Psychiatry. 2021 Feb 15;64(1):e15
pubmed: 33583453
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Front Psychiatry. 2020 Jun 05;11:533
pubmed: 32581895
BMJ Case Rep. 2020 Oct 31;13(10):
pubmed: 33130587
Int Clin Psychopharmacol. 2016 Sep;31(5):249-58
pubmed: 26974213
Bipolar Disord. 2020 Sep;22(6):641-643
pubmed: 32511859